Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-041823
Filing Date
2017-06-27
Accepted
2017-06-27 16:26:06
Documents
1
Period of Report
2017-06-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3841
  Complete submission text file 0001104659-17-041823.txt   5147
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850
Business Address
Bhatt Padmanabh P. (Reporting) CIK: 0001539215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 17932649